This result is supported by a univariate analysis using the STAD TCGA data set that reported that wild type TP53 was associated with poorer prognosis in patients with gastric cancer [45], confirming independent findings reported previously [46,47,48]. This evidence concerns the gene TP53 and gastric cancer.